Role of age and comorbidities in mortality of patients with infective endocarditis

dc.contributor.authorArmiñanzas, Carlos
dc.contributor.authorFariñas Álvarez, Concepción
dc.contributor.authorZarauza, Manuel Jesús
dc.contributor.authorMuñoz, Patricia
dc.contributor.authorGonzález Ramallo, Víctor
dc.contributor.authorMartínez Sellés Oliveria Soares, Manuel
dc.contributor.authorMiró Meda, José María
dc.contributor.authorGoenaga, Miguel Ángel
dc.contributor.authorOjeda Burgos, Guillermo
dc.contributor.authorSegura Luque, Juan Carlos
dc.contributor.authorEt al.
dc.date.accessioned2019-06-17T06:29:44Z
dc.date.available2019-06-17T06:29:44Z
dc.date.issued2019
dc.description.abstractPurpose The aim of this study was to analyse the characteristics of patients with IE in three groups of age and to assess the ability of age and the Charlson Comorbidity Index (CCI) to predict mortality. Methods Prospective cohort study of all patients with IE included in the GAMES Spanish database between 2008 and 2015.Patients were stratified into three age groups:<65 years,65 to 80 years,and ≥ 80 years.The area under the receiver-operating characteristic (AUROC) curve was calculated to quantify the diagnostic accuracy of the CCI to predict mortality risk. Results A total of 3120 patients with IE (1327 < 65 years;1291 65-80 years;502 ≥ 80 years) were enrolled.Fever and heart failure were the most common presentations of IE, with no differences among age groups.Patients ≥80 years who underwent surgery were significantly lower compared with other age groups (14.3%,65 years; 20.5%,65-79 years; 31.3%,≥80 years). In-hospital mortality was lower in the <65-year group (20.3%,<65 years;30.1%,65-79 years;34.7%,≥80 years;p < 0.001) as well as 1-year mortality (3.2%, <65 years; 5.5%, 65-80 years;7.6%,≥80 years; p = 0.003).Independent predictors of mortality were age ≥ 80 years (hazard ratio [HR]:2.78;95% confidence interval [CI]:2.32–3.34), CCI ≥ 3 (HR:1.62; 95% CI:1.39–1.88),and non-performed surgery (HR:1.64;95% CI:11.16–1.58).When the three age groups were compared,the AUROC curve for CCI was significantly larger for patients aged <65 years(p < 0.001) for both in-hospital and 1-year mortality. Conclusion There were no differences in the clinical presentation of IE between the groups. Age ≥ 80 years, high comorbidity (measured by CCI),and non-performance of surgery were independent predictors of mortality in patients with IE.CCI could help to identify those patients with IE and surgical indication who present a lower risk of in-hospital and 1-year mortality after surgery, especially in the <65-year group.spa
dc.description.filiationUEMspa
dc.description.impact4.329 JCR (2019) Q1, 26/165 Medicine, General & Internalspa
dc.description.impact1.017 SJR (2019) Q2, 35/139 Internal Medicinespa
dc.description.impactNo data IDR 2019spa
dc.description.sponsorshipSin financiaciónspa
dc.identifier.citationArmiñanzas, C., Fariñas-Alvarez, C., Zarauza, J., Muñoz, P., Ramallo, V. G., Sellés, M. M., ... & Álvarez, R. R. (2019). Role of age and comorbidities in mortality of patients with infective endocarditis. European Journal of Internal Medicine, 64, 63-71. https://doi.org/10.1016/j.ejim.2019.03.006spa
dc.identifier.doi10.1016/j.ejim.2019.03.006
dc.identifier.issn0953-6205
dc.identifier.issn1879-0828
dc.identifier.urihttp://hdl.handle.net/11268/8040
dc.language.isoengspa
dc.peerreviewedSispa
dc.rights.accessRightsrestricted accessspa
dc.subject.uemEndocarditis infecciosaspa
dc.subject.uemMortalidadspa
dc.subject.unescoEnfermedad cardiovascularspa
dc.subject.unescoMortalidadspa
dc.titleRole of age and comorbidities in mortality of patients with infective endocarditisspa
dc.typejournal articlespa
dspace.entity.typePublication
relation.isAuthorOfPublicationa14a4cbe-6878-47e7-8b7b-ffdd4a82573a
relation.isAuthorOfPublication.latestForDiscoverya14a4cbe-6878-47e7-8b7b-ffdd4a82573a

Files